The aim of the study was to determine whether serum levels of soluble ST2 (sST2) or IL-33 predict activity of the disease in patients with ANCA-associated vasculitides (AAV). The gene discussed is IL33; the disease is anti-neutrophil cytoplasmic antibody-associated vasculitis.